Clinical Trial Update: GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating GP chemotherapy in combination with anti-PD-1 and anti-TIGIT in unresectable advanced biliary tract carcinoma is ongoing, status not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Carcinoma

Drugs mentioned

• Anti-PD-1
• GP chemotherapy
• anti-TIGIT

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Biliary Tract Carcinoma | Phase 2 | Status: UNKNOWN